Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Lu

Showing results (811-820 of 818) with videos related to

Pageof 82
Sort By:
You have reached the last page of results.This site can display upto 818 results.
AIDS (London, England)|July 24, 2025
No evidence of pitavastatin effect on muscle area or density among people with HIVKristine M Erlandson, Triin Umbleja, Heather J Ribaudo, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|December 2, 2024
[A real-world study of first-line albumin-bound paclitaxel in the treatment of advanced pancreatic cancer in China]J Du, X Qiu, J Y Ni, et al.
The Lancet. HIV|April 5, 2026
Pitavastatin effects on lipids in relation to major adverse cardiovascular events: a REPRIEVE secondary analysisTriin Umbleja, Mohammad U Zafar, Sara McCallum, et al.
AIDS (London, England)|November 11, 2025
Health-related quality of life among people with HIV at low-to-moderate risk for atherosclerotic cardiovascular disease in the REPRIEVE TrialMarissa R Diggs, Sarah M Chu, Kathleen V Fitch, et al.
JACC. Cardiovascular Imaging|December 1, 2025
Statin Effects on Pericoronary Adipose Tissue Density in People With HIV: Insights From the REPRIEVE TrialBorek Foldyna, Ibrahim Hadzic, Thomas Mayrhofer, et al.
Zhonghua Yi Xue Za Zhi|December 28, 2020
[Efficacy and safety of Kangbingdu granules in the treatment of influenza: a randomized, double-blind, double-dummy, positive-drug parallel control multicenter clinical trial]Y Nong, J T Lin, X W Sun, et al.
The Lancet. HIV|March 30, 2026
Risk of obesity, diabetes, hypertension, and major adverse cardiovascular events after a switch to an integrase inhibitor: a target trial emulation in REPRIEVEEmma M Kileel, Carlos D Malvestutto, Markella V Zanni, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 16, 2025
Seroprevalence of Helicobacter pylori Infection Among Asymptomatic Patients Served by a Safety-Net Healthcare SystemAaron P Thrift, Peyman Dinarvand, Luis Juarez, et al.
Pageof 82

Showing results (811-820 of 818) with videos related to

Sort By:
Pageof 82
You have reached the last page of results.This site can display upto 818 results.
AIDS (London, England)|July 24, 2025
No evidence of pitavastatin effect on muscle area or density among people with HIVKristine M Erlandson, Triin Umbleja, Heather J Ribaudo, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|December 2, 2024
[A real-world study of first-line albumin-bound paclitaxel in the treatment of advanced pancreatic cancer in China]J Du, X Qiu, J Y Ni, et al.
The Lancet. HIV|April 5, 2026
Pitavastatin effects on lipids in relation to major adverse cardiovascular events: a REPRIEVE secondary analysisTriin Umbleja, Mohammad U Zafar, Sara McCallum, et al.
AIDS (London, England)|November 11, 2025
Health-related quality of life among people with HIV at low-to-moderate risk for atherosclerotic cardiovascular disease in the REPRIEVE TrialMarissa R Diggs, Sarah M Chu, Kathleen V Fitch, et al.
JACC. Cardiovascular Imaging|December 1, 2025
Statin Effects on Pericoronary Adipose Tissue Density in People With HIV: Insights From the REPRIEVE TrialBorek Foldyna, Ibrahim Hadzic, Thomas Mayrhofer, et al.
Zhonghua Yi Xue Za Zhi|December 28, 2020
[Efficacy and safety of Kangbingdu granules in the treatment of influenza: a randomized, double-blind, double-dummy, positive-drug parallel control multicenter clinical trial]Y Nong, J T Lin, X W Sun, et al.
The Lancet. HIV|March 30, 2026
Risk of obesity, diabetes, hypertension, and major adverse cardiovascular events after a switch to an integrase inhibitor: a target trial emulation in REPRIEVEEmma M Kileel, Carlos D Malvestutto, Markella V Zanni, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 16, 2025
Seroprevalence of Helicobacter pylori Infection Among Asymptomatic Patients Served by a Safety-Net Healthcare SystemAaron P Thrift, Peyman Dinarvand, Luis Juarez, et al.
Pageof 82